FIELD: cell biology; medicine.
SUBSTANCE: present invention relates to the field of cell biology and medicine, in particular to a method for the transfer of NK-cells to the bone marrow of a patient, and a method for the treatment of malignant neoplasm of the bone marrow. For the implementation of the specified methods, NK-cells are brought into contact with particles PM21 and/or feeding cells FC21 before the transfer of NK-cells to the body of the specified subject, and then, NK-cells are administered to the specified subject. In this case, the transfer of NK-cells to the bone marrow and, consequently, treatment is carried out due to that the specified contact of NK-cells with particles PM21 and/or feeding cells FC21 induces in NK-cells a cell mechanism inducing fucosylation of PSGL-1 on the surface of NK-cells.
EFFECT: present invention allows for the improvement of the efficiency of directed migration (homing) of NK-cells to bone marrow.
12 cl, 34 dwg, 2 ex
Title |
Year |
Author |
Number |
FORMATION OF KNOCKOUT PRIMARY AND PROPAGATED HUMAN NK CELLS USING CAS9 RIBONUCLEOPROOTEINS |
2019 |
- Li, Din Entoni
- Naejmi Kararoudi, Mejsam
|
RU2808035C2 |
METHOD FOR LONG-TERM CULTIVATION AND EXPANSION OF NK CELLS WITH HIGH VIABILITY AND FUNCTIONAL ACTIVITY |
2021 |
- Abakushina Elena Vyacheslavovna
|
RU2794770C1 |
UNIVERSAL ANTIGEN PRESENTING CELLS AND THEIR USE |
2019 |
- Ang, Sonny, O.T.
- Liu, Enli
- Rezvani, Katy
- Shpall, Elizabeth, J.
|
RU2809113C2 |
NATURAL KILLER CELLS RESISTANT TO TRANSFORMING GROWTH FACTOR BETA |
2019 |
- Li, Din Entoni
- Foltts-Stringfellou, Dzhennifer Enn
- Edvards-Mouzman, Dzhena
|
RU2830178C2 |
RECOMBINANT CELL LINE TMDK562-15 SHOWING THE ABILITY TO ACTIVATE AND PROLIFERATE HUMAN NK CELLS |
2022 |
- Abakushina Elena Vyacheslavovna
|
RU2803178C1 |
USE OF PARTICLES BASED ON CYTOPLASMIC MEMBRANE, LIPOSOMES AND EXOSOMES FOR ANALYZING ACTIVITY OF IMMUNE CELLS |
2020 |
- Li, Din Entoni
- Takkar, Aarokhi
- Kholl, Mark
- Mushinski, Dzhennifer
|
RU2829443C2 |
METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE |
2019 |
- Shpall, Elizabeth
- Rezvani, Katy
|
RU2814083C2 |
METHOD AND COMPOSITIONS FOR CELL IMMUNOTHERAPY |
2013 |
- Jensen, Michael
- Riddell, Stanley, R.
- Hudecek, Michael
|
RU2700765C2 |
COMPOSITIONS AND METHODS FOR BOOSTING THE EFFECTIVENESS OF ADOPTIVE CELL IMMUNOTHERAPY |
2015 |
- Berger Syuzanna Karolina
- Riddell Stenli R.
|
RU2716716C2 |
COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS |
2006 |
- Gol'Dshtejn Dmitrij Vadimovich
- Makarov Andrej Vital'Evich
- Arutjunjan Irina Vladimirovna
- Fatkhudinov Timur Khajsamudinovich
- Rzhaninova Alla Anatol'Evna
- Shamenkov Dmitrij Alekseevich
- Gornostaeva Svetlana Nikolaevna
- Volkov Aleksej Vadimovich
- Bochkov Nikolaj Pavlovich
|
RU2309753C1 |